Late-Occurring Vancomycin-Associated Acute Kidney Injury in Children Receiving Prolonged Therapy
- 9 July 2015
- journal article
- research article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 49 (10) , 1113-1119
Abstract
Background: Acute kidney injury (AKI) in patients receiving vancomycin has been associated with trough concentrations ≥15 mg/L and longer therapy duration. The objective of this study was to determine the incidence and factors associated with late AKI in children receiving ≥8 days of vancomycin therapy. Methods: Children aged 30 days to 17 years who were admitted to our institution and received intravenous vancomycin for at least 8 days during January to December of 2007 and 2010 and had a suspected or proven gram-positive infection were included. Late AKI was categorized as AKI occurring after the first 7 days of therapy and within 48 hours following vancomycin discontinuation. The primary outcome was incidence of late AKI as determined by modified pRIFLE criteria. Results: One-hundred sixty-seven patients were included, with a median (interquartile range) age (years) and weight (kg) of 2 (1-7) and 12.5 (8.9-23.8). Late AKI was identified in 12.6% (21/167). A higher percentage of late AKI patients received concomitant treatment with intravenous acyclovir, amphotericin products, or piperacillin-tazobactam. Age <1 year was the only factor independently associated with late AKI development (odds ratio = 4.4; 95% confidence interval = 1.3-15.4). Conclusions: Late AKI occurred in nearly 13% of children receiving ≥8 days of vancomycin therapy. This study suggests that vancomycin trough concentrations are not associated with late AKI, but that age <1 year and concomitant administration of certain nephrotoxins may be factors associated with increased risk.Keywords
This publication has 23 references indexed in Scilit:
- Factors Associated With Acute Kidney Injury in Children Receiving VancomycinAnnals of Pharmacotherapy, 2014
- Are Elevated Vancomycin Serum Trough Concentrations Achieved Within the First 7 Days of Therapy Associated With Acute Kidney Injury in Children?Journal of the Pediatric Infectious Diseases Society, 2013
- Acute Kidney Injury During Vancomycin Therapy in Critically Ill ChildrenPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
- Incidence of Nephrotoxicity and Association With Vancomycin Use in Intensive Care Unit Patients With Pneumonia: Retrospective Analysis of the IMPACT-HAP DatabaseClinical Therapeutics, 2012
- Relationship between Vancomycin Trough Concentrations and Nephrotoxicity: a Prospective Multicenter TrialAntimicrobial Agents and Chemotherapy, 2011
- Incidence and Risk Factors Influencing the Development of Vancomycin Nephrotoxicity in ChildrenThe Journal of Pediatrics, 2011
- Increasing Vancomycin Serum Trough Concentrations and Incidence of NephrotoxicityThe American Journal of Medicine, 2010
- Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases PharmacistsAmerican Journal of Health-System Pharmacy, 2009
- A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumoniaClinical Therapeutics, 2007
- High-Dose Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus InfectionsArchives of internal medicine (1960), 2006